Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA

Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen

(2022) Estrellita Uijl et al.   Journal of the American Heart Association

Hypertension: Current trends and future perspectives

(2021) Paul G. Hunter et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

(2021) Bin Zhou et al.   LANCET

Renal Denervation for Hypertension

(2021) Yousif Ahmad et al.   JACC-Cardiovascular Interventions

Targeting angiotensinogen with RNA-based therapeutics

(2020) Liwei Ren et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Effects of LCZ696 on Blood Pressure in Patients with Hypertension: A Meta-Analysis of Randomized Controlled Trials

(2020) Qiang Geng et al.   CARDIOLOGY

Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates

(2020) Christopher R Brown et al.   NUCLEIC ACIDS RESEARCH

Reversal of siRNA-mediated gene silencing in vivo

(2018) Ivan Zlatev et al.   NATURE BIOTECHNOLOGY

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

(2016) Dena Ettehad et al.   LANCET

Systematic Review and Meta-Analysis of the Prevalence of Resistant Hypertension in Treated Hypertensive Populations

(2014) Dmitrij Achelrod et al.   AMERICAN JOURNAL OF HYPERTENSION

Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

(2013) Jerome Gilleron et al.   NATURE BIOTECHNOLOGY

Nighttime Home Blood Pressure and the Risk of Hypertensive Target Organ Damage

(2012) Joji Ishikawa et al.   HYPERTENSION